Interview with Igor Krylov, CEO, Pharmstandard
You have lead this company since its beginnings in 2003, when it acquired ICN pharmaceuticals. In 2007, Pharmstandard carried out an IPO of 43% of its…
See our Cookie Privacy Policy Here